Regional-dwelling adults have higher levels of cardiovascular disease (CVD) risk.
Aims:
To determine the potential benefits of a nurse-led, self-management intervention program to reduce CVD and diabetes risk.
Methods and results:
A six-month pre/post observational study was conducted in a high risk, under-serviced regional community. A nurse-led heart health clinic was established and 530 self-selected adult individuals (mean age 54±14 years, 62% female) were subject to standardized screening. Individual targets and multidisciplinary strategies to reduce risk factors were individually tailored according to the Green Amber Red Delineation of rIsk And Need (GARDIAN) system. Changes in participants’ CVD risk factors and lifestyle behaviors were compared and independent correlates of improvements in blood pressure (BP), total cholesterol, weight and absolute CVD risk were evaluated. Baseline risk factors for CVD were highly prevalent. Participants required low (43%), moderate (34%) or high (23%) levels of surveillance and management according to GARDIAN criteria. Clinically significant changes in 326 (76%) participants were observed. Average BP decreased by 4 mmHg (systolic) and 1 mmHg (diastolic), weight by almost 1 kg, total cholesterol by 0.6 mmol/l and body mass index (BMI) by 0.3 kg/m2. A change in absolute CVD risk scores of −0.4% was observed. Primary physician attendance independently predicted improvements in BP (odds ratio (OR) 1.67; 95% confidence interval (CI) 1.08–2.58, p=0.022) whereas GARDIAN status, age, physical activity and nurse guidance positively influenced cholesterol, absolute CVD risk and weight outcomes.
Conclusions:
The feasibility and short-term benefits of a dedicated “heart health” service for high risk regional-dwelling individuals was shown.
Australian Institute of Health and Welfare 2009. Prevention of cardiovascular disease, diabetes and chronic kidney disease: targeting risk factors. Cat. no. PHE 118. Canberra: AIHW.
2.
Victorian Population Health Survey 2008. Department of Health, Melbourne, Victoria.
3.
CarringtonMJJenningsGLStewartS. Pattern of blood pressure in Australian adults: Results from a national blood pressure screening day of 13,825 adults. Int J Cardiol2010; 145: 461–467.
4.
Australian Institute of Health and Welfare 2010. Australia’s health 2010. Australia’s health series no. 12. Cat. no. AUS 122. Canberra: AIHW.
5.
Australian Bureau of Statistics. Australian Social Trends March 2011. ABS cat. no. 4102.0. Canberra: ABS.
6.
CarringtonMStewartS. Australia’s cholesterol crossroads: An analysis of 199,331 GP patient records. Melbourne, Australia: Baker IDI Heart and Diabetes Institute, 2011.
7.
CarringtonMJJenningsGLStewartS. Pressure points in primary care: Blood pressure and management of hypertension in 532050 patients from 2005 to 2010. J Hypertens2013; 31: 1265–1271.
8.
WeinehallLHellstenGBomanK. Can a sustainable community intervention reduce the health gap?–10-year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease. Scand J Public Health Suppl2001; 56: 59–68.
9.
GoldMRFranksP. A community-oriented primary care project in a rural population: Reducing cardiovascular risk. J Fam Pract1990; 30: 639–644.
10.
NguyenQNPhamSTNguyenVL. Effectiveness of community-based comprehensive healthy lifestyle promotion on cardiovascular disease risk factors in a rural Vietnamese population: A quasi-experimental study. BMC Cardiovasc Disord2012; 12: 56.
11.
SteynKRossouwJEJoostePL. The intervention effects of a community-based hypertension control programme in two rural South African towns: The CORIS Study. S Afr Med J1993; 83: 885–891.
12.
Australian Institute of Health and Welfare 2008. Medical labour force 2006. National health labour force series no. 41. Cat. no. HWL 42. Canberra: AIHW.
13.
CarringtonMJJenningsGLClarkRA. Assessing cardiovascular risk in regional areas: The Healthy Hearts Beyond City Limits program. BMC Health Serv Res2012; 12: 296.
14.
Australian Institute of Health and Welfare. Health care expenditure on cardiovascular diseases in 2004–05. Canberra, Australia: Australian Institute of Health and Welfare, 2008.
15.
WoodDAKotsevaKConnollyS. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: A paired, cluster-randomised controlled trial. Lancet2008; 371: 1999–2012.
16.
AllenJKDennison-HimmelfarbCRSzantonSL. Community Outreach and Cardiovascular Health (COACH) Trial: A randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes2011; 4: 595–602.
17.
McAlisterFAStewartSFerruaS. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials. J Am Coll Cardiol2004; 44: 810–819.
18.
CarringtonMJKokSJansenK. The Green, Amber, Red Delineation of Risk and Need (GARDIAN) management system: A pragmatic approach to optimizing heart health from primary prevention to chronic disease management. Eur J Cardiovasc Nurs2013; 12: 337–345.
19.
Australian Bureau of Statistics. 2006 Census Data Pack: Data and geographic boundaries from the 2006 census of population and housing. ABS cat. no. 2069.0.30.001. Canberra: ABS.
20.
Kris-EthertonPEissenstatBJaaxS. Validation for MEDFICTS, a dietary assessment instrument for evaluating adherence to total and saturated fat recommendations of the National Cholesterol Education Program Step 1 and Step 2 diets. J Am Diet Assoc2001; 101: 81–86.
21.
BrazierJERobertsJ. The estimation of a preference-based measure of health from the SF-12. Med Care2004; 42: 851–859.
22.
RiegelBLeeCSDicksonVV. An update on the self-care of heart failure index. J Cardiovasc Nurs2009; 24: 485–497.
23.
AlbertiKGEckelRHGrundySM. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation2009; 120: 1640–1645.
24.
Australian Bureau of Statistics. Australian Health Survey: Updated results, 2011–12. ABS cat. no. 4364.0.55.003. Canberra, Australia, 2013.
25.
KetolaESipilaRMakelaM. Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors. Ann Med2000; 32: 239–251.
26.
EllsworthDLO’DowdSCSalamiB. Intensive lifestyle modification: Impact on cardiovascular disease risk factors in subjects with and without clinical cardiovascular disease. Prev Cardiol2004; 7: 168–175.
27.
MaruthurNMWangNYAppelLJ. Lifestyle interventions reduce coronary heart disease risk: Results from the PREMIER Trial. Circulation2009; 119: 2026–2031.
28.
Pi-SunyerXBlackburnGBrancatiFL. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: One-year results of the look AHEAD trial. Diabetes Care2007; 30: 1374–1383.
29.
WisterALoewenNKennedy-SymondsH. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ2007; 177: 859–865.
30.
LawMRMorrisJKWaldNJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Brit Med J2009; 338: b1665.
31.
TaylorFWardKMooreTH. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev2011; 1: CD004816.
32.
ArtinianNTFletcherGFMozaffarianD. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: A scientific statement from the American Heart Association. Circulation2010; 122: 406–441.
33.
WingRRBolinPBrancatiFL. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med2013; 369: 145–154.
34.
PriceDRamachandranSKnightT. Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care. Br J Gen Pract2000; 50: 712–715.
35.
AndersonKMOdellPMWilsonPW. Cardiovascular disease risk profiles. Am Heart J1991; 121: 293–298.
36.
KnowlerWCBarrett-ConnorEFowlerSE. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med2002; 346: 393–403.
37.
TuomilehtoJLindstromJErikssonJG. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med2001; 344: 1343–1350.
38.
DunkleyAJCharlesKGrayLJ. Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: Systematic review and mixed treatment comparison meta-analysis. Diabetes Obes Metab2012; 14: 616–625.
39.
LowensteynIJosephLLevintonC. Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med1998; 27: 730–737.
